Skip to main content
. 2021 Mar 1;93(5):3165–3175. doi: 10.1002/jmv.26876

Figure 4.

Figure 4

Risk for unfavorable outcomes in patients with SARS‐CoV‐2 RNAemia versus patients without detectable SARS‐CoV‐2 RNA. SARS‐CoV‐2 RNA, severe acute respiratory syndrome coronavirus 2 RNA